ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
The third external evaluation of the European Centre for Disease Prevention and Control (ECDC) was initiated in 2018, in line with the requirements of the Centre’s Founding Regulation. The final report is now published together with the conclusions and recommendations of the Management Board.
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.
In 2018, 37 527 cases of hepatitis C were reported in 29 EU/EEA Member States. The number is 37 427 when countries that only reported acute cases are excluded, which corresponds to a crude rate of 8.8 cases per 100 000 population.
In 2019, 37 733 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases leaves 37 660 cases, which corresponds to a crude rate of 8.9 cases per 100 000 population.